Clinical trials show Zepbound delivering up to 22.5% average body weight loss, compared to Wegovy's 14.9%, according to the Obesity Medicine Association
Research in people with type 2 diabetes has found that GLP-1 users have a higher chance of gallbladder and bile duct problems compared with those on other diabetes medications
Always confirm with lab work before changing your levothyroxine dose
10.1186/s13619-020-00064-2 196 YanJ
10.1038/nature14344 Summary Keywords iron deficiency, tumor progression, immune response, tumor metabolism, therapeutic targets Citation Lin L, Yin X and Guan Y (2025) Decoding iron deficiency in cancer: mechanisms, immune modulation, and therapeutic potential
Withdraw the needle and check that you have the correct volume